Fortress Biotech, Inc.
FBIO
$3.86
$0.277.52%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 246.32% | -56.45% | 47.42% | -17.53% | 28.99% |
| Total Depreciation and Amortization | -2.94% | 5.87% | 17.55% | -19.65% | 0.00% |
| Total Amortization of Deferred Charges | 52.88% | -1.67% | -22.88% | -48.54% | 24.14% |
| Total Other Non-Cash Items | -406.01% | -308.12% | 50.04% | 64.55% | 40.61% |
| Change in Net Operating Assets | -127.45% | 48.02% | -17.79% | -96.01% | -143.83% |
| Cash from Operations | -40.88% | -51.57% | 35.65% | 8.15% | 13.98% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 422.40% | 107.77% | -- | -- | -- |
| Total Debt Issued | -- | -- | -85.14% | 573.36% | -- |
| Total Debt Repaid | 100.00% | 0.00% | 0.00% | -- | -- |
| Issuance of Common Stock | -45.07% | 66.91% | -91.63% | 246.62% | -79.21% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | 23.33% | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | 100.00% | 0.00% |
| Other Financing Activities | -92.24% | 149.54% | 154.07% | -528.87% | -52.12% |
| Cash from Financing | -91.33% | 102.05% | 851.90% | -81.00% | -48.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -150.24% | 1,706.09% | 87.89% | -129.08% | -406.35% |